Labeling has helped to identify the illegal sale of drugs on 100 million roubles

The company “R-farm” thanks to the marking system was able to identify the illegal sale of drugs by about 100 million rubles. This was stated by the Director of the health Economics of the company Alexander Bykov, writes TASS.

“The damage we have prevented through the introduction of labelling of medicines only for several of our drugs is about hundreds of millions of rubles”, – said Bykov, adding that it also allowed to prevent risk to the health and lives of patients.

Bulls noted that the marking ensures the quality present in the pharmaceutical drug market, the increase in the cost of medicines due to the introduction of marking is not expected.

Mandatory labelling of all drugs circulating in the Russian market will be launched in July 2020.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

“Nanolek” released the first batch of hydroxychloroquine

The company “Nanolek” factory in the Kirov region has established the production of one of the drugs for the treatment of coronavirus infection of hydroxychloroquine. Currently, hydroxychloroquine is included in the treatment protocols in the interim Ministry of health recommendations for the prevention, diagnosis and treatment of new coronavirus infection. The first batch of this […]

Igor Ghahramanyan was returned to the Ministry of health

Senator Igor Ghahramanyan was appointed first Deputy Minister of health of the Russian Federation. In the Federation Council Ghahramanyan presented the Executive authority of the Yaroslavl region and held the position of first Deputy Chairman of Committee on social policy, writes “Kommersant”. From 2012 to 2017 Igor Ghahramanyan was already a Deputy and first Deputy […]

AstraZeneca localized in Russia production of ticagrelor

Company AstraZeneca localized at its own plant in Kaluga region manufacture of the finished dosage form of ticagrelor 90 mg for the treatment of patients with acute coronary syndrome (ACS). Ticagrelor (trade name of Brilinta) is included in the list of essential drugs and included in the standards of specialized medical care for patients with […]